Cargando…
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
BACKGROUND: Ovarian cancer remains an on-going challenge mainly due to the development of drug resistance and also because the cancer is likely to have metastasized at the time of diagnosis. Currently, chemotherapy based on platinum drugs such as cisplatin is the primary treatment for the disease. C...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826510/ https://www.ncbi.nlm.nih.gov/pubmed/24209693 http://dx.doi.org/10.1186/1757-2215-6-78 |